Dawn raids for pharmaceutical sector inquiry

DG Competition press notice stating that it is conducting unannounced inspections at generic and research-based pharmaceuticals manufacturers in order to obtain information for a wide-ranging investigation into competition law compliance in the sector. The focus appears to be on the alleged misuse of patents or patent settlements rather than on parallel trade by itself.

For further information or advice please contact Franck Latrémolière.

Filed under Article 81, Article 82, DG Competition, Healthcare, Pharmaceuticals.

Reckon LLP is an economics consultancy with expertise in data analysis, economic regulation and competition law.

About Reckon